申请人:HADDACH Mustapha
公开号:US20110065712A1
公开(公告)日:2011-03-17
The invention provides compounds that inhibit CK2 and/or Pim kinases and compositions containing such compounds. These tricyclic compounds and compositions containing them are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, pathogenic infections, and certain immunological disorders.
本发明提供了抑制CK2和/或Pim激酶的化合物和含有这些化合物的组合物。这些三环化合物及其含量有用于治疗增殖性疾病,如癌症,以及其他激酶相关疾病,包括炎症,疼痛,病原体感染和某些免疫性疾病。